rx 821002 has been researched along with 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone in 1 studies
| Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone) | Trials (2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone) | Recent Studies (post-2010) (2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone) |
|---|---|---|---|---|---|
| 317 | 0 | 45 | 35 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenup, JL; Leverenz, JB; Peskind, ER; Raskind, MA; Szot, P; White, SS | 1 |
1 other study(ies) available for rx 821002 and 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone
| Article | Year |
|---|---|
Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Dendrites; Female; Fluoxetine; Hippocampus; Humans; Idazoxan; In Situ Hybridization; Lewy Body Disease; Locus Coeruleus; Male; Middle Aged; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Prazosin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; RNA, Messenger; Tetralones; Tyrosine 3-Monooxygenase | 2006 |